Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4955147011 | Valproate sodium 333 mg and valproic acid 145 mg prolonged-release oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4955148018 | Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4955149014 | Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has manufactured dose form | Extended-release oral tablet | true | Inferred relationship | Some | ||
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Plays role | Anticonvulsant therapeutic role | true | Inferred relationship | Some | ||
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has precise active ingredient | Valproic acid | true | Inferred relationship | Some | 1 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has BoSS | Valproic acid | true | Inferred relationship | Some | 1 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has precise active ingredient | Valproate sodium | true | Inferred relationship | Some | 2 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has BoSS | Valproate sodium | true | Inferred relationship | Some | 2 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet | Is a | Valproic acid only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR